Search Site
Home >> Research Area >> Angiogenesis

Angiogenesis

Angiogenesis is the physiological process through which new blood vessels form from pre-existing vessels. In precise usage this is distinct from vasculogenesis, which is the de novo formation of endothelial cells from mesoderm cell precursors, and from neovascularization, although discussions are not always precise (especially in older texts). The first vessels in the developing embryo form through vasculogenesis, after which angiogenesis is responsible for most, if not all, blood vessel growth during development and in disease.

Products for Angiogenesis

  1. Cat.No. Product Name Information
  2. BCC1266 PCI-32765 (Ibrutinib) Bruton's tyrosine kinase (BTK) inhibitor PCI-32765 (Ibrutinib)
  3. BCC1385 AVL-292 Btk inhibitor AVL-292
  4. BCC1473 CGI-1746 Btk inhibitor CGI-1746
  5. BCC1575 Firategrast α4β1/α4β7 integrin antagonist Firategrast
  6. BCC2070 Zaurategrast Integrin inhibitor Zaurategrast
  7. BCC2227 FG-4592 (ASP1517) HIF prolyl-hydroxylase inhibitor FG-4592 (ASP1517)
  8. BCC2229 IOX2(Glycine) HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor IOX2(Glycine)
  9. BCC3590 Cyclo (-RGDfK) Inhibitor of αvβ3 integrin Cyclo (-RGDfK)
  10. BCC3642 ML161 Inhibits PAR1-mediated platelet activation ML161
  11. BCC3644 DMXAA (Vadimezan) mSTING agonist; induces antitumor immunological responses DMXAA (Vadimezan)
  12. BCC3920 QL47 BTK kinase inhibitor QL47
  13. BCC3921 RN486 Btk inhibitor,potent and selective RN486
  14. BCC3942 Cilengitide Potent and selective inhibitor of integrins αvβ3 and αvβ5 Cilengitide
  15. BCC3944 A 205804 Selective inhibitor of E-selectin and ICAM-1 expression A 205804
  16. BCC3945 BIO 1211 Selective α4β1 (VLA-4) inhibitor BIO 1211
  17. BCC3946 A 286982 Potent inhibitor of the LFA-1/ICAM-1 interaction A 286982
  18. BCC3947 SLIGRL-NH2 PAR2-activating peptide SLIGRL-NH2
  19. BCC3948 TFLLR-NH2 PAR1-activating peptide TFLLR-NH2
  20. BCC3949 AY-NH2 Selective PAR4 agonist AY-NH2
  21. BCC3950 Thrombin Receptor Agonist Peptide Causes platelet aggregation and secretion Thrombin Receptor Agonist Peptide
  22. BCC3951 AC 55541 Potent and selective PAR2 agonist AC 55541
  23. BCC3952 AC 264613 PAR2 receptor agonist AC 264613
  24. BCC3953 VKGILS-NH2 Control peptide for SLIGKV-NH2 VKGILS-NH2
  25. BCC3954 RLLFT-NH2 Control peptide for TFLLR-NH2 RLLFT-NH2
  26. BCC3955 LRGILS-NH2 Control peptide for SLIGRL-NH2 LRGILS-NH2
  27. BCC3956 PAR 4 (1-6) PAR4 agonist PAR 4 (1-6)
  28. BCC3957 TRAP-6 PAR1 peptide fragment (residues 42-47); acts as a PAR1 agonist TRAP-6
  29. BCC3958 2-Furoyl-LIGRLO-amide Potent and selective PAR2 agonist 2-Furoyl-LIGRLO-amide
  30. BCC3959 SLIGKV-NH2 PAR2 receptor agonist SLIGKV-NH2
  31. BCC4100 PCI 29732 Potent BTK inhibitor PCI 29732
  32. BCC4131 BAY 87-2243 HIF-1 inhibitor,potent and selective BAY 87-2243
  33. BCC4238 Btk inhibitor 1 Btk inhibitor 1
  34. BCC4266 TR-14035 α4β7 and α4β1 integrins antagonist TR-14035
  35. BCC4394 CNX-774 BTK inhibitor, orally active, irreversible and selective CNX-774
  36. BCC5094 Plinabulin (NPI-2358) vascular disrupting agent Plinabulin (NPI-2358)
  37. BCC5124 PCI-32765 Racemate BTK inhibitor PCI-32765 Racemate
  38. BCC5125 Btk inhibitor 1 R enantiomer Btk inhibitor 1 R enantiomer
  39. BCC5349 RGD (Arg-Gly-Asp) Peptides Inhibits integrin binding to RGD motifs RGD (Arg-Gly-Asp) Peptides
  40. BCC5548 CWHM-12 CWHM-12
  41. BCC5988 Echistatin, α1 isoform αVβ3 and glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor Echistatin, α1 isoform
  42. BCC6080 TCS 2314 TCS 2314
  43. BCC6216 TC-I 15 TC-I 15
  44. BCC6229 LDV FITC Fluorescent ligand for α4β1 (VLA-4) LDV FITC
  45. BCC6275 P11 Potent antagonist of αvβ3-vitronectin interaction; antiangiogenic P11
  46. BCC6332 Leukadherin 1 Allosteric activator of CD11b/CD18 Leukadherin 1
  47. BCC6402 FG2216 HIF-prolyl hydroxylase inhibitor FG2216
  48. BCC6463 ONO-4059 Highly potent and selective oral Btk inhibitor ONO-4059
  49. BCC6472 LFM-A13 BTK-specific tyrosine kinase inhibitor LFM-A13
  50. BCC6501 SB273005 αvβ3 antagonist SB273005
  51. BCC6998 GR 144053 trihydrochloride GR 144053 trihydrochloride
  52. BCC7089 Combretastatin A4 Tubulin polymerization inhibitor. Antitumor, antiangiogenic and antimetastatic Combretastatin A4
  53. BCC7458 OGT 2115 Heparanase inhibitor. Antiangiogenic OGT 2115
  54. BCC7694 RGDS peptide Integrin binding sequence; inhibits integrin receptor function RGDS peptide
  55. BCC8002 BIO 5192 α4β1 inhibitor BIO 5192

Items 1 to 54 of 54 total